Related references
Note: Only part of the references are listed.PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI plus Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer
Camille Evrard et al.
DIGESTIVE AND LIVER DISEASE (2021)
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100
Markus Moehler et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated nk cell infiltration and epithelial-mesenchymal transition in gastric cancer
Huafu Li et al.
Aging-US (2021)
Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival
Zhi-guo Shan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Expression, regulation and clinical significance of B7-H3 on neutrophils in human gastric cancer
Zheng-Yan Li et al.
CLINICAL IMMUNOLOGY (2021)
Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
Ronan J. Kelly et al.
CLINICAL CANCER RESEARCH (2020)
Regulatory B cells in infection, inflammation, and autoimmunity
Subhajit Dasgupta et al.
CELLULAR IMMUNOLOGY (2020)
Tumor Immunology and Tumor Evolution: Intertwined Histories
Jerome Galon et al.
IMMUNITY (2020)
Fatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma
Run Lin et al.
CANCER IMMUNOLOGY RESEARCH (2020)
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
Kellsye P. Fabian et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
Shogo Kumagai et al.
IMMUNITY (2020)
CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils
Zheying Mao et al.
ONCOGENESIS (2020)
DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
Linbin Yang et al.
NATURE (2020)
Ramucirumab in Combination with Pembrolizumab in Treatment-Naive Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial
Ian Chau et al.
CANCERS (2020)
Knockdown of serine/threonine-protein kinase 24 promotes tumorigenesis and myeloid-derived suppressor cell expansion in an orthotopic immunocompetent gastric cancer animal model
Hui-Ping Hsu et al.
JOURNAL OF CANCER (2020)
A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis
Zhijun Zhou et al.
CLINICAL CANCER RESEARCH (2019)
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study
Yung-Jue Bang et al.
GASTRIC CANCER (2019)
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial
Hyun Cheol Chung et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer
WeiHong Ren et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer
Hong-Tao Hu et al.
EXPERIMENTAL CELL RESEARCH (2019)
Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study
Yong Lv et al.
GUT (2019)
Adenosine Generated by Regulatory T Cells Induces CD8+ T Cell Exhaustion in Gastric Cancer through A2aR Pathway
Linsen Shi et al.
BIOMED RESEARCH INTERNATIONAL (2019)
A selective sphingosine-1-phosphate receptor 1 agonist SEW-2871 aggravates gastric cancer by recruiting myeloid-derived suppressor cells
Yujing Zhou et al.
JOURNAL OF BIOCHEMISTRY (2018)
Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer
Liu Yang et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2018)
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma
Toshihiko Doi et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Lessons learned from the blockade of immune checkpoints in cancer immunotherapy
Xiaolei Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
Kohei Shitara et al.
LANCET (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E
Peiming Zheng et al.
CELL DEATH & DISEASE (2018)
CD45(+)CD33(low)CD11b(dim) myeloid-derived suppressor cells suppress CD8(+) T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancer
Fang-yuan Mao et al.
CELL DEATH & DISEASE (2018)
Tumor-derived exosomes induce PD1(+) macrophage population in human gastric cancer that promotes disease progression
Furong Wang et al.
ONCOGENESIS (2018)
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Charles S. Fuchs et al.
JAMA ONCOLOGY (2018)
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300
Y. -J. Bang et al.
ANNALS OF ONCOLOGY (2018)
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
Yelena Y. Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)
Jonas A. de Souza et al.
CANCER (2017)
Interleukin-17-Producing Neutrophils Link Inflammatory Stimuli to Disease Progression by Promoting Angiogenesis in Gastric Cancer
Tuan-Jie Li et al.
CLINICAL CANCER RESEARCH (2017)
Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
Ting-ting Wang et al.
GUT (2017)
STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells
Macarena Garrido-Tapia et al.
IMMUNOBIOLOGY (2017)
Natural Killer Cells: Angels and Devils for Immunotherapy
Beatriz Martin-Antonio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
DKK3 attenuates the cytotoxic effect of natural killer cells on CD133(+) gastric cancer cells
Pu Xia et al.
MOLECULAR CARCINOGENESIS (2017)
Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B Cell Antigens in Human Malignancies
Hiroto Katoh et al.
CELL REPORTS (2017)
Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells
Hao-Chen Wang et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer
Liu-sheng Peng et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The Prognostic and Clinicopathological Significance of Tumor-Associated Macrophages in Patients with Gastric Cancer: A Meta-Analysis
Songcheng Yin et al.
PLOS ONE (2017)
CD155T/TIGIT Signaling Regulates CD8+ T-cell Metabolism and Promotes Tumor Progression in Human Gastric Cancer
Weiling He et al.
CANCER RESEARCH (2017)
Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
Yung-Jue Bang et al.
CLINICAL CANCER RESEARCH (2017)
Financial Toxicity of Cancer Care: It's Time to Intervene
S. Yousuf Zafar
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Financial Toxicity of Cancer Care: It's Time to Intervene
S. Yousuf Zafar
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility
Kensuke Shiraishi et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer
Caitlin R. Meeker et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Erik Ames et al.
JOURNAL OF IMMUNOLOGY (2015)
CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer
Weiwei Wang et al.
ONCOTARGET (2015)
The Development of a Financial Toxicity Patient-Reported Outcome in Cancer The COST Measure
Jonas A. de Souza et al.
CANCER (2014)
Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype
Ana Ferro et al.
EUROPEAN JOURNAL OF CANCER (2014)
Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y1086, c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity
A. P. Cardoso et al.
ONCOGENE (2014)
Effects of Gastric Cancer Cells on the Differentiation of Treg Cells
Jing-Lan Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience
S. Yousuf Zafar et al.
ONCOLOGIST (2013)
Immune Regulatory Function of B Cells
Claudia Mauri et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity
Shuli Zhao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
Julie S. Nielsen et al.
CLINICAL CANCER RESEARCH (2012)
Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer
Hiroaki Saito et al.
GASTRIC CANCER (2012)
Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo
Janine Gotot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Conversion of Intratumoral Regulatory T Cells by Human Gastric Cancer Cells is Dependent on Transforming Growth Factor-β1
Xiaoming Lu et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1
Xiang-Liang Yuan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
Christy Ralph et al.
CLINICAL CANCER RESEARCH (2010)
Natural Killer Cell Cytotoxicity and Immunosuppressive Cytokines (IL-10, TGF-beta 1) in Patients with Gastric Cancer
Andrzej Szkaradkiewicz et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
NKG2D ligands:: key targets of the immune response
Segundo Gonzalez et al.
TRENDS IN IMMUNOLOGY (2008)
Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function
DB Stetson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Tumor necrosis factor signaling
H Wajant et al.
CELL DEATH AND DIFFERENTIATION (2003)
Share Paper
